Bristol-Myers pays $300 million for Cambridge biotech
Drug giant Bristol-Myers Squibb Co. has agreed to pay $300 million to buy a two-year-old Cambridge biotech that's developing treatments for cancers and other diseases.
from Biotech News
Drug giant Bristol-Myers Squibb Co. has agreed to pay $300 million to buy a two-year-old Cambridge biotech that's developing treatments for cancers and other diseases.
The most important thing is to improve and not stop. Even if you have taken some course, this does not mean that you are now a guru. You need to constantly practice, learn something new.
0 Comments